Viewing nowCombinationEmpacombi Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.

MFDS item code 202201335 · Approved 2022.04.04 · Insurance code 645211000
Improvement of glycemic control in adults with type 2 diabetes
This medication effectively enhances blood sugar control in adult patients with Type 2 diabetes when combined with dietary management and exercise. It is particularly suitable for patients whose blood sugar levels are not adequately controlled, and additional information from a specialist is recommended for patients with a history of cardiovascular disease. This medication improves blood sugar control, aiding in the management of diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication helps control blood sugar levels. While taking this medication, there is a risk of a rare side effect called lactic acidosis, so caution is advised. When used in conjunction with other diabetes medications, hypoglycemic symptoms may occur, so care must be taken. Patients with moderate to severe renal impairment, acute kidney issues, severe infections, heart problems, etc., should not take this medication. Pregnant or breastfeeding women are also advised not to take this medication. During treatment, regular monitoring of kidney function is necessary to ensure there are no abnormalities, and if dehydration, severe vomiting, diarrhea occurs, cessation of the medication should be discussed with a doctor. Additionally, this medication should be discontinued at least 48 hours prior to surgery and resumed only after kidney function has returned to normal post-surgery. This medication may increase the risk of urinary or genital infections, so immediate treatment is necessary if infection symptoms appear. During treatment, be alert for hypoglycemic symptoms, especially if using insulin or other hypoglycemic agents, as dose adjustment may be needed to reduce the risk of hypoglycemia. Vitamin B12 levels may decrease, so regular testing is required for long-term use. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided during treatment. Patients taking this medication should be cautious of symptoms related to fluid volume depletion, especially elderly patients or those with cardiovascular diseases. In case of overdose, immediate hospital treatment should be sought, and dialysis may be required. This medication is not recommended for children, and elderly patients should start with the minimum dose while frequently monitoring kidney function. Finally, this medication should be stored out of reach of children, and it should be kept in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain room temperature between 1 and 30 degrees Celsius to ensure the efficacy and safety of the medication over time.
Yellow, brownish, bilayer, biconvex, film-coated tablet
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.